Novartis Stock
Novartis Stock price
Key metrics
Create a Free Account to create an Novartis alert.
Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.
Novartis Stock Analysis
Analyst Opinions
32 Analysts have issued a Novartis forecast:
Analyst Opinions
32 Analysts have issued a Novartis forecast:
Financial data from Novartis
| Jun '25 |
+/-
%
|
||
| Revenue | 44,087 44,087 |
12%
12%
|
|
| Gross Profit | 33,558 33,558 |
14%
14%
|
|
| EBITDA | 14,959 14,959 |
45%
45%
|
EBIT (Operating Income) EBIT | 14,748 14,748 |
45%
45%
|
| Net Profit | 10,976 10,976 |
16%
16%
|
|
In millions CHF.
Don't miss a Thing! We will send you all news about Novartis directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Novartis Stock News
Company Profile
Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
| Head office | Switzerland |
| CEO | Vasant Narasimhan |
| Employees | 76,057 |
| Founded | 1996 |
| Website | www.novartis.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
